Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A4 | P26447 | 7/20 | 1.00 |
| ▸ | PAX8 | Q06710 | 5/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 8/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.82 |
| ▸ | THRB | P10828 | 7/20 | 0.82 |
| ▸ | BLM | P54132 | 7/20 | 0.82 |
| ▸ | RECQL | P46063 | 6/20 | 0.82 |
| ▸ | BRCA1 | P38398 | 6/20 | 0.82 |
| ▸ | TOP2A | P11388 | 5/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.82 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.82 |
| ▸ | MAPT | P10636 | 4/20 | 0.82 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.82 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.82 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.82 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1485948 | 1.00 | S100A4 (1.00) | S100A4PAX8HSP90AA1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL31237243 | 0.99 | S100A4 (0.99) | S100A4PAX8HSP90AA1MEN1KMT2A | |
| SCHEMBL17514312 | 0.94 | S100A4 (0.90) | S100A4PAX8HSP90AA1MEN1KMT2A | |
| SCHEMBL28160200 | 0.94 | S100A4 (0.89) | S100A4PAX8HSP90AA1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL31238308 | 0.93 | S100A4 (0.86) | S100A4PAX8HSP90AA1MEN1KMT2A | |
| SCHEMBL7805182 | 0.93 | S100A4 (0.86) | S100A4PAX8HSP90AA1MEN1KMT2A | |
| SCHEMBL29338082 | 0.92 | S100A4 (1.00) | S100A4PAX8HSP90AA1MEN1KMT2A | |
| SCHEMBL8639928 | 0.92 | S100A4 (1.00) | S100A4PAX8HSP90AA1MEN1KMT2A | |
| SCHEMBL3036863 | 0.92 | S100A4 (0.86) | S100A4PAX8HSP90AA1MEN1KMT2A | |
| SCHEMBL29132019 | 0.92 | S100A4 (0.85) | S100A4PAX8HSP90AA1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122042909-A | Eggshell quality evaluation method and eggshell quality optimization feed for poultry cultivation | 石家庄塞纽信生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2025103457-A1 | SIRNA FOR INHIBITING LPA EXPRESSION AND USE THEREOF | 纳肽得(青岛)生物医药有限公司 | 2025-05-22 | — | — | WO | claimed |
| CN-120020252-A | SiRNA for inhibiting LPA expression and application thereof | 纳肽得(青岛)生物医药有限公司 | 2025-05-20 | — | — | CN | claimed |
| CN-120005877-A | SiRNA for inhibiting expression of complement factor B and application thereof | 纳肽得(青岛)生物医药有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-122042909-A | Eggshell quality evaluation method and eggshell quality optimization feed for poultry cultivation | 石家庄塞纽信生物科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| WO-2025109003-A1 | P-CADHERIN LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025103457-A1 | SIRNA FOR INHIBITING LPA EXPRESSION AND USE THEREOF | 纳肽得(青岛)生物医药有限公司 | 2025-05-22 | — | — | WO | disclosed |
| CN-120020252-A | SiRNA for inhibiting LPA expression and application thereof | 纳肽得(青岛)生物医药有限公司 | 2025-05-20 | — | — | CN | disclosed |
| CN-120005877-A | SiRNA for inhibiting expression of complement factor B and application thereof | 纳肽得(青岛)生物医药有限公司 | 2025-05-16 | — | — | CN | disclosed |
| US-20240124889-A1 | COMPOSITIONS AND METHODS FOR THE VECTORED AUGMENTATION OF PROTEIN DESTRUCTION, EXPRESSION AND/OR REGULATION | VOYAGER THERAPEUTICS, INC. | 2024-04-18 | — | — | US | disclosed |
| US-20220389449-A1 | COMPOSITIONS FOR THE TREATMENT OF DISEASE | VOYAGER THERAPEUTICS, INC. | 2022-12-08 | — | — | US | disclosed |
| US-11326182-B2 | Compositions for the treatment of disease | VOYAGER THERAPEUTICS, INC. (US) | 2022-05-10 | — | — | US | disclosed |